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Abstract
Background: There is increasing interest in developing human cell lines to be used to better understand cell biology, but
also for drug screening, toxicology analysis and future cell therapy. In the endocrine pancreatic field, functional human beta
cell lines are extremely scarce. On the other hand, rodent insulin producing beta cells have been generated during the past
years with great success. Many of such cell lines were produced by using transgenic mice expressing SV40T antigen under
the control of the insulin promoter, an approach clearly inadequate in human. Our objective was to develop and validate in
rodent an alternative transgenic-like approach, applicable to human tissue, by performing somatic gene transfer into
pancreatic progenitors that will develop into beta cells.
Methods and Findings: In this study, rat embryonic pancreases were transduced with recombinant lentiviral vector
expressing the SV40T antigen under the control of the insulin promoter. Transduced tissues were next transplanted under
the kidney capsule of immuno-incompetent mice allowing insulinoma development from which beta cell lines were
established. Gene expression profile, insulin content and glucose dependent secretion, normalization of glycemia upon
transplantation into diabetic mice validated the approach to generate beta cell lines.
Conclusions: Somatic gene transfer into pancreatic progenitors represents an alternative strategy to generate functional
beta cell lines in rodent. Moreover, this approach can be generalized to derive cells lines from various tissues and most
importantly from tissues of human origin.
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Introduction
Islets of Langerhans are micro-organs scattered throughout the
pancreas, and responsible for synthesizing and secreting pancreatic
hormones. They produce hormones such as insulin (beta cells),
glucagon (alpha cells) somatostatin (delta cells) and pancreatic
polypeptide (PP cells). Insulin-secreting beta cells play a major role
and are involved in the development of diabetes. Type 1 diabetes
results from autoimmune destruction of pancreatic beta cells, while
type 2 diabetes is caused by a combination of insulin resistance and
inadequate insulin secretion. Thus, in both type 1 and type 2
diabetes, the functional pancreatic beta cell mass is not sufficient to
control glycemia. Over the past decades research in the beta cell
field profited from the establishment of insulin-secreting cell lines.
Many rodent cell lines were produced from adult beta cells such as
RIN and INS1 cells derived from x-ray induced adult rat
insulinoma [1,2] and HIT cells generated by simian virus 40
transformation of adult hamster islet cells [3]. Others were
established from transgenic mice expressing SV40T antigen under
the control of the insulin promoter [4–9]. Such rodent cell lines
were extremely useful for a better understanding of beta cell
biology. Attempts were next made to generate human beta cell
lines using the strategies developed for rodent cell lines.
Unfortunately, the majority of the attempts were not successful.
In the present work, our objective was to validate alternative
transgenic approaches to generate beta cell lines using a procedure
that can be transferred to human. Specifically, we asked whether
beta cell lines can be generated from embryonic pancreatic
explants by somatic gene transfer into pancreatic progenitor cells
that will differentiate into beta cells.
For this purpose, we transduced immature rat pancreatic tissues
with recombinant lentiviral vector expressing SV40T antigen
under the control of the insulin promoter. Our data demonstrate
that such vector can transduce pancreatic stem/progenitors, that
will differentiate into beta cells expressing the SV40T antigen and
form insulinoma from which beta cell lines can be derived. This
PLoS ONE | www.plosone.org 1 March 2009 | Volume 4 | Issue 3 | e4731strategy that mimics transgenic-like approach represents a new
process to generate beta cell lines that can be applicable to human
tissue.
Results
Tumour formation from rat embryonic pancreases
transduced with recombinant lentiviruses expressing the
SV40T antigen under the control of the insulin promoter
We previously demonstrated that mature insulin producing cells
can be stably modified by transduction of pancreatic progenitors
with recombinant lentiviruses expressing eGFP under the control
of the insulin promoter [10]. Here, we asked whether such an
approach could be used to generate beta cell lines by transduction
of pancreatic progenitors with recombinant lentiviruses expressing
the SV40T antigen under the control of the insulin promoter.
Lentiviral vectors expressing either SV40T antigen (pTRIP
DU3.RIP405-SV40T) or eGFP (pTrip DU3.RIP405-eGFP) under
the control of a 405 bp fragment of the rat insulin promoter were
used to transduce immature E13 rat embryonic pancreases that
were transplanted under the kidney capsule of immuno-incompe-
tent scid mice. One month later, the grafted tissues were removed
and analyzed. The size of the grafted tissue was enlarged when
tissues were transduced with viral vectors expressing SV40T
antigen when compared to transduction with viral vectors
expressing eGFP (Fig. 1, compare panels A and B). When
SV40T antigen transduced pancreases were removed 3 months
after transplantation, the size of the tissue was even higher
(Fig. 1C). In the grafts, insulin expression was monitored by in situ
hybridization. While some insulin-expressing cells were detected in
pancreases transduced with viral vectors expressing eGFP, their
number was hugely increased in pancreases transduced with
SV40T expressing viral vectors (Fig. 1, compare panels D and F).
Similarly, proliferation of insulin-expressing cells detected by BrdU
incorporation was largely increased in grafts transduced with
SV40T compared to eGFP expressing viral vectors (Fig. 1,
Figure 1. Development of the infected tissue after transplantation. A–C: Pancreatic epithelia were transduced with pTrip DU3.RIP405-eGFP
(A) or pTRIP DU3.RIP405-SV40T (B, C), transplanted and analyzed one (A, B) or three months later (C). D–G: Insulin detection by in situ hybridization
(blue) on 10 mm sections on grafts removed one month after transplantation. In D and E, grafts was transduced with pTrip DU3.RIP405-eGFP. In F
and G, graft was transduced with pTRIP DU3.RIP405-SV40T. E, G: Double staining for insulin (blue) and BrdU (brown). Pancreatic tissue is circled with
a dotted line, k: kidney. Scale bars: A–C 2 mm; D, F 1 mm; E, G 25 mm.
doi:10.1371/journal.pone.0004731.g001
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pancreases transduced with viral vectors expressing SV40T
antigen was next analyzed at the protein level. As expected,
insulin-positive cells expressed SV40T antigen (Fig. 2, panels A–
C). They also expressed Pdx1, a transcription factor crucial for
beta cell development and function [11] (Fig. 2, panels D–F) and
incorporate BrdU (Fig. 2, panels G–I).
Establishment of rat pancreatic beta cell lines
To establish pancreatic beta cell lines, grafts were removed,
dissociated and transduced with viral vectors expressing the
neomycin resistance gene under the control of the insulin
promoter for further selection of insulin-transcribing cells by
culture in the presence of G418 (Fig. 3A). Using this protocol,
different cell lines were established and one of them, RYAS41 was
further analyzed. As shown in Fig. 3B, RYAS41 cells expressed
insulin, C-peptide and SV40T antigen. They also express the
nuclear transcription factor Pdx1 and proliferate based on their
capacity to incorporate BrdU. Such cell lines can be frozen and
thawed and its features are stable at least until passage 54.
RYAS41 cell line expresses beta cell specific markers and
secretes insulin in response to glucose stimulation
RYAS41 lack expression of Ngn3 and Pax4 (Fig. 4A), two
transcription factors expressed in pancreatic endocrine progenitor
cells [12,13] and either absent [13] or expressed at very low levels
Figure 2. Immunohistochemical analysis of grafts developed in Scid mice. A–C: Staining for insulin (red), SV40T (green) and DAPI (blue); D–
F: Staining for insulin (red), Pdx1 (green) and DAPI (blue); G–I: Staining for insulin (red), BrdU (green) and DAPI (blue). Scale bars: 25 mm
doi:10.1371/journal.pone.0004731.g002
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such as amylase was not detected in RYAS41 cells (Fig. 4A).
We next compared by quantitative RT PCR the expression profile
of RYAS41 to the well characterized 832/13 INS-1 cells [15]. We
analyzed the expression of three transcription factors Pdx1, NeuroD1
and Nkx6.1 and many genes important for beta cell function such as
P c s k 1 ,P c s k 2 ,A b c c 8 ,G l u t 2 ,G l u c o k i n a s e ,S n a p 2 5a n dR a b 3 A .F o r
all markers tested, the expression in RYAS41 cells was in the same
range as the one found in 832/13 INS-1 cells (Fig. 4B). Moreover,
insulin1 mRNA expression was identical in RYAS41 cells when
compared to 832/13 INS-1 cells (Fig. 4B). At the protein level, the
insulin content per cell was 2.1 fold lower in RYAS41 cells when
compared to 832/13 INS-1 cells (0.32+/20.04 vs 0.69+/20.07 pg
of insulin per cell respectively). When normalized to total protein,
RYAS41 and 832/13 INS-1 cells contain 2.87+/20.6 and 6.92+/
20.81 ng insulin / mg protein respectively.
Figure 3. Immunocytochemical Characterization of RYAS41 cells. A: Schematic representation of the culture procedure used to derive the
RYAS41 cell line. P represents passage number. Surface of the culture well is indicated below the time line. B: Coexpression of insulin (red) and SV40T
(green); insulin (red) and c-peptide (green), insulin (red) and Pdx1 (green); and double staining for insulin (red) and BrdU (green). Scale bars: 25 mm.
doi:10.1371/journal.pone.0004731.g003
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glucose stimulation in the presence or absence of IBMX. A 7.6 fold
induction of insulin secretion was observed in presence of 20 mM
glucose (Figure 4C). Importantly, IBMX was able to potentiate
insulin secretion. Indeed, a 20.5 fold induction is observed with
20 mM glucose in the presence of IBMX compared to 2.8 mM
glucose conditions (Fig. 4C).
Transplanted RYAS41 cells restore normoglycemia in
diabetic mice
To define whether RYAS41 cells were functional, scid mice were
injected with streptozotocin for beta cells destruction and two days
later, insulin capsules were subcutaneously implanted to hyper-
glycemic mice to maintain normoglycemia. Sixteen days after STZ
injection, half of the mice (n=7) were transplanted with 10
6
RYAS41 while the other 7 were used as control. At day 38, insulin
release by the implanted capsules lasted and glycemia of non
transplanted mice was increased and remained high up to the end
of the experiments (72 days), demonstrating the efficacy of beta cell
destruction by streptozotocin. On the other hand, glycemia of
transplanted mice remained in the normal range (Fig. 5). When
unilateral nephrectomies were performed to remove the grafts,
mice became hyperglycemic establishing that in streptozotocin-
treated mice, glycemia was controlled by the grafted cells. As
expected, when transplanted animals were kept for a longer
period, severe hypoglycemia systematically occurred 80–90 days
after transplantation due to expansion of tumoral RYAS41 cells
(data not shown).
Discussion
Production of human pancreatic beta cells in large amount
represents a crucial objective for 2 main reasons: such beta cells
would be useful for screening of new drugs that can modulate beta
cell function and most importantly, pancreatic beta cells could be
used for cell therapy of diabetes. Different approaches have been
previously developed to generate pancreatic beta cells in large
amount. A first one consisted in using as starting material
embryonic stem cells (ES cells) to produce beta cells. The major
advantage is that ES cells self-renew indefinitely in culture, and
have the capacity to differentiate to multiple cell types, and thus to
pancreatic beta cells. Quite a large amount of publications
appeared during the past years on beta cell production from
mouse ES cells [16] and more recently with human ES cells [17–
19]. However, mass production of pure beta cells could not be
achieved with such process [19].
A second approach to generate large amounts of beta cells was
based on the production of pancreatic beta cell lines using adult
pancreas as a starting material. First experiments were performed
with rodent tissues. The rat cell lines RIN and INS and the
hamster cell line HIT were obtained using this approach [1–3]. In
2005, a human beta cell line NAKT-15 was produced using
human adult islets as starting material [20]. While this cell line
seemed functional and stable, to the best of our knowledge, since
2005, no information was published with this line. Thus, while
major efforts were developed to generate human beta cell lines
from adult islets [20–23] only one human beta cell line was
developed [20], demonstrating the importance of generating
additional human beta cell lines and of defining alternative
strategies.
A third approach was to derivate beta cell lines from beta cell
tumours derived from transgenic mice expressing SV40T antigen
under the control of the insulin promoter. There, the immortal-
izing gene is expressed in beta cells as early as insulin is transcribed
[4–9]. Such lines were extremely useful as a model to deeply study
mouse beta cells [24]. However, since beta cell lines were obtained
by gene transfer in fertilized eggs, its application is restricted to
animal models without any possible transfer to human.
Recently, we demonstrated that immature embryonic pancreas
transduced with recombinant lentiviral vectors resulted in
endocrine cell differentiation and restricted cell type expression
of the transgene according to the specificity of the promoter used
in the viral construct. Specifically, when eGFP was placed under
the control of the insulin promoter, a majority of the developed
beta cells expressed eGFP [10]. Thus recombinant lentiviral
vectors can efficiently transduce pancreatic progenitor cells and
Figure 4. Gene expression profile in RYAS41 and glucose-
stimulated insulin secretion. A: Semi-quantitative RT PCR compar-
ison between RYAS41, lung (negative control) and pancreas (positive
control) from E17 rat embryos. PCR products after 40 amplification
cycles are analyzed on a 2% agarose gel. B: CT (threshold cycle) value
are normalized to cyclophilin and presented as fold increase compared
to 832/13 INS-1 cells. Values are means+/2S.E.M. of Q-PCR performed in
duplicates from 3 independent RNA extractions. C: RYAS41 secrete
insulin in response to glucose stimulation. Insulin secreted into the
medium is presented as % of insulin content secreted per hour. Values
are means+/2S.E.M. of three independent cell cultures.
doi:10.1371/journal.pone.0004731.g004
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asked whether such an approach could be used to generate beta
cell lines. If that was the case, it would mimic the approach used to
generate beta cell lines form transgenic mice [4–9]. This will
generate a transgenic like organ without gene transfer in fertilized
eggs thus enabling such an approach to be used in human.
Here, we demonstrated the efficiency of the approach using rat
embryonic pancreases. We first developed an approach to generate
insulinoma by transducing rat embryonic pancreatic epithelia with
recombinant lentiviral vectors expressing the SV40T antigen under
the control of the insulin promoter. Here we show that rat
embryonic pancreatic epithelia transduced with SV40T antigen
expressing lentiviral vectorssystematicallydevelop insulinoma when
grafted under the kidney capsule of scid mice (38 out of 38). This
grafting site has beenshown to be permissive for the development of
many organs such as ovarian cortex, thyroid, skin and airway [25–
28]. Importantly, we previously demonstrated that pancreatic beta
cellsproperlydevelopfromhumanimmatureembryonicpancreases
under such conditions [10,29,30]. In this study, we selectively
immortalized insulin producing cells using immature embryonic
pancreatic bud as starting material. Neither acinar cells nor
glucagon-expressing endocrine cells were obtained through this
selective process. Furthermore, the derived insulin producing cell
line did not express immature endocrine markers such as Ngn3 and
Pax4. These cells are mature and express a series of beta cell
transcription factors such as Pdx1, Nkx6.1, Pax6 and NeuroD1.
They also express molecules crucial for beta cell function such as
Pcsk1 and Pcsk2 that participate in the processing of proinsulin to
insulin and C-peptide, Abcc8 that codes for the sulfonyurea
receptor, Glut2 and glucokinase that are important for glucose
stimulated insulin secretion, Snap25 the Synaptosomal-associated
protein 25 kDa and Rab3A a small G protein, member of the Rab
family and glucokinase[31]. Such molecules were expressed in
similar amounts in Ryas41 cells when compared to well
characterized 832/13 INS-1 cell line [15]. RYAS41 cells secrete
insulin in response to glucose stimulation, but unexpectedly, insulin
secretion is highly induced by IBMX at 2.8 mM glucose which is
not the case in primary beta cells [32,33]. Moreover, the percentage
of insulin content secreted per hour under stimulated conditions is
much higher to what observed with primary islets and beta cell lines
[2]. Such differences will be investigated in the future. At this point,
RYAS41 cells are not clonal but sub-clones could be established to
improveregulatedinsulin secretionasdescribed forINS-1cells[24].
Insulin mRNA level and insulin content in RYAS41 and 832/13
INS-1 cell line are similar but remained lower than the ones found
in primary beta cells [34]. Finally, upon transplantation, RYAS41
cells regulate the glycemia of NOD/scid mice deficient in
endogenous beta cells.
Our current objective is to transfer to human the above
described validated technology with the goal of generating
functional human beta cell lines. Our past and current data
support the feasibility of this objective. First, beta cells develop
from human fetal pancreas grafted under the kidney capsule of
immunoincompetent mice [29]. Next, we recently established
conditions for somatic gene transfer in human fetal pancreatic
progenitors allowing stable transgene expression into beta cells
[35]. Finally, our preliminary data indicate that human insulinoma
develop upon SV40T antigen gene transfer into human pancreatic
progenitors using the above described approach.
In conclusion, we described in the present work a new approach
based on somatic gene transfer applicable to human tissues to
generate functional beta cell lines starting from rat embryonic
pancreas. This strategy provides an interesting novel route to
generate human beta cell lines and also cell lines from other
specific cell types using SV40 T antigen under the control of other
cell type specific promoters.
Materials and Methods
Ethical Statement
All animals were handled in strict accordance with good animal
practice as defined by the French animal welfare bodies, and all
Figure 5. Transplanted RYAS41 cells restore normoglycemia in diabetic mice. Fourteen scid mice were injected with streptozotocin. Two
days later, 3-weeks lasting insulin capsules were subcutaneously implanted to hyperglycemic mice. Two weeks later, half of the mice were
transplanted under the kidney capsule with 10
6 RYAS41 cells. Grafted cells were removed by nephrectomy at day 66. Values are means+/2S.E.M.
doi:10.1371/journal.pone.0004731.g005
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DNA constructs and recombinant lentiviral productions
The backbone of the lentiviral construct, pTRIP, has been
previously described [36]. The lentiviral vector, pTRIP
DU3.RIP405-eGFP expresses eGFP under the control of the Rat
insulin II gene promoter (RIP) [10]. New lentiviral vectors pTRIP
DU3.RIP405-LargeT and pTRIP DU3.RIP405 –NEO were
constructed in order to express, under the control of the insulin
promoter, the SV40T antigen or the neomycin resistance gene
respectively. First the eGFP cassette was removed from pTRIP
DU3.RIP405-eGFP by BamHI and KpnI restriction. The
following linker, gatcgccccgggcgggatccggtac with BamHI and
KpnI cohesive ends was ligated to the linearized plasmid resulting
in the pTRIP DU3.RIP405-linker containing downstream of the
insulin promoter SmaI, BamHI and KpnI unique cloning sites in
the 59 to 39 orientation. A BamHI insert containing the entire
coding region of the SV40T antigen (kindly provided by B.
Thorens) was ligated to a BamHI linearized pTRIP DU3.RIP405-
linker. The complete coding region of the neomycin resistance
gene was amplified from the pcDNA 3 plasmid (Invitrogen,
Carlsbad, CA) by PCR using the following primers: BamHI-Neo
sense: 59gaggaggatccCGCATGATTGAACAAGATGG 39 and
KpnI-Neo antisens 59 cccaaggtaccCGCTCAGAAGAACTCGT-
CAAG 39. The resulting PCR product was digested with both
BamHI and KpnI and ligated in a BamHI, KpnI linearized
pTRIP DU3.RIP405-linker. To rule out PCR induced mutations
the neomycin resistance coding region was entirely sequenced.
Lentiviral vector stocks were produced by transient transfection
of 293T cells with the p8.7 encapsidation plasmid (DVprDVifDV-
puDNef) [37], pHCMV-G encoding the VSV glycoprotein-G [37]
and the pTRIP DU3 recombinant vector as previously described
[36]. The supernatants were treated with DNAse I (Roche
Diagnostic, Meylan, France) prior to ultracentrifugation and the
resulting pellet was resuspended in PBS, aliquotted and frozen at
280uC until use. The amount of p24 capsid protein was
quantified by the HIV-1 p24 ELISA antigen assay (Beckman
Coulter, Villepinte, France). All infections were normalized
relative to p24 capsid protein quantification.
Preparation of pancreatic rudiments, infection and
transplantation
Pregnant Wistar rats were obtained from Janvier (CERJ, Le
Genest, France). All animal manipulations were performed
according to the guidelines of the French Animal Care
Committee. The morning post coitum was designated as
embryonic day 0.5 (E0.5). Pregnant female rats at E13.5 days of
gestation were sacrificed by cervical dislocation. The embryos
were harvested on E13.5 and dissected. The dorsal pancreatic bud
was dissected and the epithelium was mechanically separated from
the surrounding mesenchyme as described [38,39].
Recombinant lentiviruses were used to transduce embryonic
pancreatic epithelia. Briefly, 1 mg of p24 of either pTrip
DU3.RIP405-eGFP or pTRIP DU3.RIP405-SV40T was pre-
incubated in a final volume of 45 ml of RPMI 1640 medium
supplemented with 10% heat inactivated fetal calf serum containing
HEPES (10 mM), L-glutamine (2 mM), non essential amino acid
(Invitrogen) and penicillin (100 units/ml)-streptomycin (100 mg/ml)
and DEAE-dextran (20 mg/ml). After 15 min at 37uCo fp r e -
incubation the viral solution was added to 45 ml of Hepes Buffered
Saline Solution (HBSS, Invitrogen) containing 10 pancreatic
epithelia. After 2 hours of infection, tissues were washed twice in
culture medium and grown overnight in three-dimensional collagen
gels asdescribedpreviously [38,39].The followingday, theepithelia
were removed from the collagen matrix and used for transplanta-
tion into severe combined immunodeficient (scid) mice.
Male scid mice (Charles River Laboratories, L’arbresle, France)
were maintained in isolators. Using a dissecting microscope, 10
infected pancreatic epithelia were implanted under the kidney
capsule as previously described [29,30]. At different time points
after transplantation, the mice were sacrificed, the kidney
removed, and the graft dissected. Tissues were either fixed and
used for immunohistological analysis or for in situ hybridization or
used to establish beta cell lines. Some mice were pulsed with BrdU
(Sigma-Aldrich, Saint-Quentin Fallavier, France) 2 hour before
sacrifice for cell proliferation analysis.
Graft dissociation and culture and establishment of a
beta cell line
Three month after transplantation scid mice were sacrificed by
cervical dislocation and the grafts were removed, cut into pieces in
a sterile cabinet and weighted. and treated with 200 units of type
IV collagenase in 500 ml of HBSS during 20 min at 37uC. The
digested tissue was centrifuged for 10 min at 2000 rpm and the
resulting pellet was resuspended in culture medium containing
DMEM, 15% heat inactivated fetal calf serum, 0.5% 2-
mercaptoethanol and penicillin (100 units/ml)-streptomycin
(100 mg/ml). The suspension was mechanically dissociated in a
1 ml syringe by successive passages through 21, 22, 25, 27 and 30
gauge needles. The dissociated cells were centrifuged 10 min at
2000 rpm and resuspended in a volume of 300 ml of culture
medium per 50 mg of initial tissue and seeded on a poly-L-lysine /
laminin coated 1.5 cm
2 culture wells.
After 24 hours of culture, cells were infected at 37uC with 60 ng
of p24 capsid protein of pTRIP DU3.RIP405 –NEO in 200 mlo f
culture medium supplemented with 10 mg/ml of DEAE dextran.
One hour later, the medium was replaced by 1 ml of fresh
medium. G418 (Sigma) was added in the medium at a final
concentration of 1 mg/ml 2 weeks after infection. For the first 10
passages the cells seeded in coated wells of either equivalent or
double surface in order to achieve a two fold dilution. Passage was
performed when cell confluence was observed. From passage 11, a
2/5 dilution was performed every week to amplify the cell line.
Tissue preparation for histological analysis
Tissue fixation was performed by intracardiac perfusion of 4%
paraformaldehyde (PFA) freshly prepared in phosphate buffered
saline (PBS). Then, different post fixation procedures were applied.
For immuno-detection on paraffin sections perfused tissues were
postfixed 6 hours in 3.7% formaldehyde then dehydrated and
embedded in paraffin. 4 mm sections were performed and used for
immunofluorescent co-detection for both insulin/Pdx1 and insulin
insulin/BrdU.Forfrozensection,theperfusedtissueswerepostfixed
for 2 hours in 4% PFA then cryoprotected in 15% sucrose prepared
in PBS for 48 hours. The tissues werenextembedded in 7% gelatin,
15% sucrose prepared in PBS, frozen at 250uC in isopentan and
10 mm sections were performed. Such tissues were used for
immunofluorescent co-detection of insulin/SV40T antigen. For in
situ hybridization, cryo-sections were performed on as describe
above after a 24 hours postfixation period.
Immunohistochemical procedures on tissue sections and
RYAS41 cell line
Immunofluorescent staining was performed as previously de-
scribed [38]. For immunofluorescent detection on Ryas 41 cells,
12 mm glass cover slips were coated with poly-L-lysine / laminin in
b-Cell Lines from Progenitors
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2 culture well. 1.2 10
5 RYAS41 cells were seeding and
cultured for 5 days. Two hours before fixation a BrdU (10 mM) was
added to the culture medium. Next, cells were fixed in 4% PFA.
The following antibodies were used: Rabbit anti-Pdx1 poly-
clonal antibody (1/1000) [38]; guinea pig anti insulin antibody (1/
400, DakoCytomation, Trappes, France); rabbit anti-insulin
antibody (1/200, Diasorin, Anthony, France); mouse anti-BrdU
(1/2, Amersham, France), and mouse anti-SV40T (1/50,
Calbiochem Merck Biosciences, San Diego, CA) and anti-rabbit
C-peptide (1/1000, Beta Cell Biology Consortium). The fluores-
cent secondary antibodies were fluorescein anti-rabbit antibody
(1/200; Jackson Immunoresearch Laboratories, Beckman Coul-
ter); fluorescein anti-mouse antibody (1/200, Immunotech,
Marseille, France) and Texas-red anti-guinea pig antibodies (1/
200; Jackson Immunoresearch Laboratories).
In situ hybridization coupled with BrdU
immunohistochemical detection
The proinsulin probe was prepared as previously described [40].
Plasmids were linearized and used as templates for the synthesis of
antisense riboprobes by T3 RNA polymerase (Promega), in the
presence of digoxygenin-UTP (Roche diagnostic). Colorimetric
revelations were performed with 5-bromo-4-chloro-3-indolyl phos-
phate (Promega) and nitroblue tetrazolium (Promega) for digox-
ygenin-UTP.
After in situ hybridization, BrdU incorporation was visualized
by immunohistochemical analysis using an anti-BrdU antibody
(1:500; Becton Dickinson) and biotinylated anti-mouse secondary
antibodies (1:200).
Digital photographs
Photographs were taken either using a fluorescent microscope
(Leica; Leitz, Rockleigh, NJ) and digitized using a cooled three-
chip charge coupled– device camera (Hamamatsu C5810;
Hamamatsu, Middlesex, NJ) or using an Axioskop microscope
(Zeiss) and a color vision digital camera (Donpisha).
RNA isolation, reverse transcription and real-time-PCR
Total RNA was isolated from RYAS41 and 832/13 INS-1 cell
lines [15], and lung and pancreas from E17 rat embryos using the
Quiagen RNeasy microkit (Quiagen). cDNA was prepared using
Superscript (Invitrogen) and Quantitative real-time RT-PCR was
performed using assays-on-demand kits and an ABI Prism 7300
sequence detector (both from Applied Biosystems, Foster City,
Ca), according to the manufacturer’s instructions. For Ngn3, Pax4
and Amylase PCR products obtained after 40 cycles were also
loaded on a 2% agarose gel.
Insulin secretion and insulin contents
RYAS41 cells (3.10
5 cells) were seeded in coated wells. 3 days
latercellswereincubatedovernight with culturemediumcontaining
2.8 mM Glucose. Cell were next washed twice with HEPES-
buffered Krebs-Ringer buffer (KRB) (119 mmol/l NaCl,
4.74 mmol/l KCl, 2.54 mmol/l CaCl2, 1.19 mmol/l MgSO4,
1.19 mmol/l KH2PO4, 25 mmol/l NaHCO3, 10 mmol/l HEPES
at pH 7.4,and 0.1% bovine serum albumin[BSA] [Sigma]). Insulin
secretion was measured by using static incubation for a 90-minutes
period in KRB containing 2.8 mM or 2.8 mM Glucose supple-
mented in the presence or absence of 0.5 mM IBMX. Insulin
secretion and content were measured by radio-immuno-assay using
the Diasorin INSIK-5 kit according to manufacturer instructions
RYAS41 transplantation in diabetic mice
To determine the ability of the RYAS41 cell line to regulate the
glycemia of the diabetic mice, scid mice were injected with a
solution of Streptozotocin (STZ; 250 mg/kg of body weight;
Sigma-Aldrich) freshly prepared in citrate buffer to destroy beta
cells. Glucose concentrations were measured on blood collected
from the tail vein, using a portable glucose meter (GlucoMen, A.
Menarini diagnostics, Firenze, Italy). Two days after STZ
injection, mice bearing a blood glucose concentration above
4 g/l were implanted subcutaneously with a 3 week lasting insulin
capsule (Sustained Release Insulin Implants; LinShin, Scarbor-
ough, Canada) in order to normalize the glycemia before RYAS41
transplantation. Two weeks later, half of the treated mice were
transplanted with 10
6 RYAS41 cells using the following proce-
dure. Briefly, RYAS41 cells were harvested, centrifuged 10 min a `
4uC. The cell pellet was resuspended in 12 ml of ice cold matrigel
(BD Bioscience) and placed in a silicon cylinder at 37uCt o
polymerize. Then the cylinder containing the RYAS41 cells was
transplanted under the kidney capsule of STZ treated mice. To
confirm the contribution of the RYAS41 graft to the normaliza-
tion of blood glucose values in the host mice, grafts were removed
by unilateral nephrectomy at the end of the experiment.
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